Dauntless Investment Group, LLC 13D and 13G filings for AEON Biopharma, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-03-03 1:51 pm Purchase | 2025-02-26 | 13G | AEON Biopharma, Inc. AEON | Dauntless Investment Group, LLC | 108,224 9.700% | 108,224 (New Position) | Filing |